Study identifier:D1960C00003
ClinicalTrials.gov identifier:N/A
EudraCT identifier:2009-009940-22
CTIS identifier:N/A
A Phase I, Single-Centre, Randomised, Double-Blind, Placebo Controlled Single-Ascending Dose, Study to Assess the Safety, Tolerability, Pharmacokinetics of AZD8529 in Healthy Male Japanese Subjects
Healthy
Phase 1
Yes
AZD8529, Placebo
Male
48
Interventional
20 Years - 45 Years
Allocation: Randomized
Endpoint Classification: Safety Study
Intervention Model: Parallel Assignment
Masking: Double Blind
Primary Purpose: Basic Science
Verified 01 Aug 2009 by AstraZeneca Pharmaceuticals
AstraZeneca Pharmaceuticals
-
No locations available
Arms | Assigned Interventions |
---|---|
Experimental: 1 | Drug: AZD8529 Oral |
Placebo Comparator: 2 | Drug: Placebo Oral |